Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.

Cheng JW, Vu H.

Clin Ther. 2012 Apr;34(4):766-87. doi: 10.1016/j.clinthera.2012.02.022. Epub 2012 Mar 22. Review.

PMID:
22444784
[PubMed - indexed for MEDLINE]
2.

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.

Bovio JA, Smith SM, Gums JG.

Ann Pharmacother. 2011 May;45(5):603-14. doi: 10.1345/aph.1P644. Epub 2011 May 3. Review.

PMID:
21540406
[PubMed - indexed for MEDLINE]
3.

Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Baetz BE, Spinler SA.

Pharmacotherapy. 2008 Nov;28(11):1354-73. doi: 10.1592/phco.28.11.1354. Review.

PMID:
18956996
[PubMed - indexed for MEDLINE]
4.

Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.

Burness CB, McKeage K.

Drugs. 2012 May 7;72(7):963-86. doi: 10.2165/11209080-000000000-00000. Review.

PMID:
22564134
[PubMed - indexed for MEDLINE]
5.

Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Garnock-Jones KP.

Am J Cardiovasc Drugs. 2011;11(1):57-72. doi: 10.2165/11206400-000000000-00000.

PMID:
21265583
[PubMed - indexed for MEDLINE]
6.

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.

Ma TK, Yan BP, Lam YY.

Pharmacol Ther. 2011 Feb;129(2):185-94. doi: 10.1016/j.pharmthera.2010.09.005. Epub 2010 Oct 12. Review.

PMID:
20920530
[PubMed - indexed for MEDLINE]
7.

Dabigatran etexilate: A novel oral direct thrombin inhibitor.

Blommel ML, Blommel AL.

Am J Health Syst Pharm. 2011 Aug 15;68(16):1506-19. doi: 10.2146/ajhp100348. Review.

PMID:
21817082
[PubMed - indexed for MEDLINE]
8.

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P; BISTRO II Study Group.

J Thromb Haemost. 2005 Jan;3(1):103-11.

PMID:
15634273
[PubMed - indexed for MEDLINE]
9.

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.

Lip GY, Larsen TB, Skjøth F, Rasmussen LH.

J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9.

PMID:
22575324
[PubMed - indexed for MEDLINE]
Free Article
10.

Dabigatran etexilate.

Sanford M, Plosker GL.

Drugs. 2008;68(12):1699-709.

PMID:
18681492
[PubMed - indexed for MEDLINE]
11.

The pharmacology and therapeutic use of dabigatran etexilate.

Sarah S.

J Clin Pharmacol. 2013 Jan;53(1):1-13. doi: 10.1177/0091270011432169. Epub 2013 Jan 24. Review.

PMID:
23400738
[PubMed - indexed for MEDLINE]
12.

Dabigatran etexilate in venous thromboembolism.

Ferrer E.

Drugs Today (Barc). 2009 Oct;45(10):715-24. doi: 1396674/dot.2009.45.10.1425728. Review.

PMID:
20069135
[PubMed - indexed for MEDLINE]
13.

Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.

Evans HC, Perry CM, Faulds D.

Drugs. 2004;64(6):649-78. Review.

PMID:
15018597
[PubMed - indexed for MEDLINE]
14.

Dabigatran etexilate: a new thrombin inhibitor.

Verma AK.

Med J Aust. 2010 Apr 5;192(7):407-12.

PMID:
20367591
[PubMed - indexed for MEDLINE]
15.

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

Eriksson BI, Dahl OE, Ahnfelt L, Kälebo P, Stangier J, Nehmiz G, Hermansson K, Kohlbrenner V.

J Thromb Haemost. 2004 Sep;2(9):1573-80.

PMID:
15333033
[PubMed - indexed for MEDLINE]
16.

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

Stangier J.

Clin Pharmacokinet. 2008;47(5):285-95. Review.

PMID:
18399711
[PubMed - indexed for MEDLINE]
17.

Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin.

Tran A, Cheng-Lai A.

Cardiol Rev. 2011 May-Jun;19(3):154-61. doi: 10.1097/CRD.0b013e3182137758. Review.

PMID:
21464643
[PubMed - indexed for MEDLINE]
18.

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kälebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Büller HR; RE-MODEL Study Group.

J Thromb Haemost. 2007 Nov;5(11):2178-85.

PMID:
17764540
[PubMed - indexed for MEDLINE]
19.

Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.

Siddiqui FM, Qureshi AI.

Expert Opin Pharmacother. 2010 Jun;11(8):1403-11. doi: 10.1517/14656566.2010.482931. Review.

PMID:
20446854
[PubMed - indexed for MEDLINE]
20.

Dabigatran: new drug. Continue to use heparin, a better-known option.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):97-9.

PMID:
19637411
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk